ISA PHARMACEUTICALS
Dead / Abandoned — Abandoned — no statement of use filed (as of 08 Oct 2025)
What this means for you
This application is over — abandoned 08 Oct 2025. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97208181
- Mark type
- Stylized text
- Filed
- 07 Jan 2022
- Published for opposition
- 22 Nov 2022
- Abandoned
- 08 Oct 2025
- Attorney of record
- Peter Nussbaum
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical and medicinal preparations for the treatment of viral infections, cancer and pre-cancerous disorders; active pharmaceutical substances based on synthetic long peptides which may be modified to improve the immune response and may be combined with other pharmaceutical products for the treatment of viral infections, cancer and pre-cancerous disorders; immune response adjuvants for medical purposes; pharmaceutical compounds for treating viral infections, cancer and pre-cancerous disorders by means of immune system modulation
Owner
- ISA Pharmaceuticals B.V., Leiden, NL
- ISA Pharmaceuticals B.V., Leiden, NL
Prosecution history
- 08 Oct 2025 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 08 Oct 2025 — ABANDONMENT - NO USE STATEMENT FILED
- 27 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2024 — SOU EXTENSION 3 GRANTED
- 27 Jun 2024 — SOU EXTENSION 3 FILED
- 27 Jun 2024 — SOU TEAS EXTENSION RECEIVED
- 15 Dec 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Dec 2023 — SOU EXTENSION 2 GRANTED
- 13 Dec 2023 — SOU EXTENSION 2 FILED
- 13 Dec 2023 — SOU TEAS EXTENSION RECEIVED
- 14 Jul 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jul 2023 — SOU EXTENSION 1 GRANTED
- 12 Jul 2023 — SOU EXTENSION 1 FILED
- 12 Jul 2023 — SOU TEAS EXTENSION RECEIVED
- 26 Jan 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED